These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1711945)
1. A cross-sectional study of platelet cyclic AMP in healthy and hypertensive pregnant women. Horn EH; Cooper J; Hardy E; Heptinstall S; Rubin PC Clin Sci (Lond); 1991 Jun; 80(6):549-58. PubMed ID: 1711945 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal studies of platelet cyclic AMP during healthy pregnancy and pregnancies at risk of pre-eclampsia. Horn EH; Cooper JA; Hardy E; Heptinstall S; Rubin PC Clin Sci (Lond); 1995 Jul; 89(1):91-9. PubMed ID: 7545563 [TBL] [Abstract][Full Text] [Related]
3. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase. Kowalska MA; Rao AK; Disa J Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717 [TBL] [Abstract][Full Text] [Related]
4. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor. Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526 [TBL] [Abstract][Full Text] [Related]
5. Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia. Louden KA; Broughton Pipkin F; Heptinstall S; Fox SC; Mitchell JR; Symonds EM Br J Obstet Gynaecol; 1991 Dec; 98(12):1239-44. PubMed ID: 1777456 [TBL] [Abstract][Full Text] [Related]
6. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP. Fisch A; Michael-Hepp J; Meyer J; Darius H Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414 [TBL] [Abstract][Full Text] [Related]
7. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders. Gresele P; Blockmans D; Deckmyn H; Vermylen J J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms involved in agonist-induced hyperaggregability of platelets from normal pregnancy. Sheu JR; Hsiao G; Lin WY; Chen TF; Chien YY; Lin CH; Tzeng CR J Biomed Sci; 2002; 9(1):17-25. PubMed ID: 11810021 [TBL] [Abstract][Full Text] [Related]
9. Modulation by cyclic AMP of arachidonic acid-induced platelet desensitization. Hatmi M; Rotilio D; Haye B; Antonicelli F; Joseph D; Vargaftig BB Eur J Pharmacol; 1986 Dec; 132(2-3):219-28. PubMed ID: 3028837 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Iloprost, Cicaprost and prostacyclin effects on cyclic AMP metabolism in intact platelets. Ashby B Prostaglandins; 1992 Mar; 43(3):255-61. PubMed ID: 1378640 [TBL] [Abstract][Full Text] [Related]
11. Lanthanum stimulates the accumulation of cyclic AMP and inhibits secretion and thromboxane B2 formation in human platelets. Best LC; Bone EA; Jones PB; Russell RG Biochim Biophys Acta; 1980 Oct; 632(2):336-42. PubMed ID: 6251913 [TBL] [Abstract][Full Text] [Related]
12. The regulation of platelet aggregation in vitro by interleukin-1beta and tumor necrosis factor-alpha: changes in pregnancy and in pre-eclampsia. Bar J; Zosmer A; Hod M; Elder MG; Sullivan MH Thromb Haemost; 1997 Oct; 78(4):1255-61. PubMed ID: 9364994 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of S-(1,2-dicarboxyethyl)glutathione on collagen-induced platelet aggregation; enhancements of cyclic AMP level and adenylate cyclase activity in platelets by S-(1,2-dicarboxyethyl)glutathione. Tsuboi S; Fujiwara E; Ogata K; Sakaue A; Nakayama T; Ohmori S Biol Pharm Bull; 1993 Nov; 16(11):1083-6. PubMed ID: 8312859 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Haslam RJ; Davidson MM; Desjardins JV Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136 [TBL] [Abstract][Full Text] [Related]
15. Effects of nitric oxide donors in vitro on the arachidonic acid-induced platelet release reaction and platelet cyclic GMP concentration in pre-eclampsia. Hardy E; Rubin PC; Horn EH Clin Sci (Lond); 1994 Feb; 86(2):195-202. PubMed ID: 8143430 [TBL] [Abstract][Full Text] [Related]
16. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions. Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369 [TBL] [Abstract][Full Text] [Related]
17. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets. Best LC; Martin TJ; Russell RG; Preston FE Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414 [No Abstract] [Full Text] [Related]
18. Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin. Jaschonek K; Faul C; Daiss W; Weisenberger H Prostaglandins Leukot Med; 1986 Oct; 24(2-3):199-206. PubMed ID: 2432618 [TBL] [Abstract][Full Text] [Related]
19. Aberrant adenylyl cyclase/cAMP signal transduction and G protein levels in platelets from hypertensive patients improve with antihypertensive drug therapy. Marcil J; Schiffrin EL; Anand-Srivastava MB Hypertension; 1996 Jul; 28(1):83-90. PubMed ID: 8675269 [TBL] [Abstract][Full Text] [Related]
20. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets. Williams KA; Murphy W; Haslam RJ Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]